NLRP3 and gastric cancer: Notably, the overexpression of the lncRNA ADAMTS9-AS2 inhibits gastric cancer progression and promotes cisplatin chemosensitivity by regulating the miR-223-3p/NLRP3 axis-mediated pyroptosis process.